biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a15c-01a-31d-a12b-09
biospecimen_aliquot__bcr_aliquot_uuid	10c594a1-0843-4740-9d96-00211a9509fb
biospecimen_aliquot__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099017194
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a12b
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	6.40
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__a260_a280_ratio	1.90
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a15c-01a-31d
biospecimen_analyte__bcr_analyte_uuid	9d86f1ec-9a1b-4435-8a6e-1c0b9331b864
biospecimen_analyte__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a15c
biospecimen_diagnostic_slides__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	26e13415-1d37-43c7-9ebb-4411be7fce10
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a15c
biospecimen_normal_control__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_normal_control__ncedna_dna_conc	0.312
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	65
biospecimen_normal_control__normal_tissue_anatomic_site	other
biospecimen_portion__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_portion__bcr_portion_barcode	tcga-e2-a15c-01a-31
biospecimen_portion__bcr_portion_uuid	54ce08d5-35dc-436e-a202-049588bbd349
biospecimen_portion__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_portion__date_of_creation	2010-12-27
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	31
biospecimen_portion__portion_sequence	3
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a15c-01a-31d
biospecimen_protocol__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_sample__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_sample__bcr_sample_uuid	31f45863-c419-4a07-896c-722b9724ce76
biospecimen_sample__days_to_collection	393
biospecimen_sample__initial_weight	200
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a15c.04ff2cf1-737b-4fd2-8a1d-f9b5488de510.pdf
biospecimen_sample__pathology_report_uuid	04ff2cf1-737b-4fd2-8a1d-f9b5488de510
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	b003e078-2c0b-42bc-ad2e-adb171765c57
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a15c-01a-21-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
biospecimen_slide__bcr_sample_barcode	tcga-e2-a15c-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a15c-01a-03-tsc
biospecimen_slide__bcr_slide_uuid	19c1b196-81cc-46f9-8e36-59e833b6e369
biospecimen_slide__image_file_name	tcga-e2-a15c-01a-03-tsc.19c1b196-81cc-46f9-8e36-59e833b6e369.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	100
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a15c
biospecimen_tumor_sample__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
clinical_drug__bcr_drug_barcode	tcga-e2-a15c-d18936
clinical_drug__bcr_drug_uuid	057d51bb-cbbc-401e-bb09-3e7a10adca74
clinical_drug__bcr_patient_barcode	tcga-e2-a15c
clinical_drug__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
clinical_drug__form_completion_date	2011-11-9
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	65
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-e2-a15c-f18935
clinical_follow_up__bcr_followup_uuid	c22968bc-ce2c-417d-b613-7801b0f89a52
clinical_follow_up__bcr_patient_barcode	tcga-e2-a15c
clinical_follow_up__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-11-9
clinical_follow_up__last_contact_days_to	694
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	61
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage i
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	right lower outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a15c
clinical_patient__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
clinical_patient__birth_days_to	-22583
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-13
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.02
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	20-29%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	497
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	4
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a15c
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a15c
clinical_radiation__bcr_patient_uuid	da840a22-8d30-4682-bbd0-8fa87bd40528
clinical_radiation__bcr_radiation_barcode	tcga-e2-a15c-r18937
clinical_radiation__bcr_radiation_uuid	b2859f7d-ef4c-413b-bdf2-d76014910fbf
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-11-9
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	102
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	55
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A15C-01A-31D-A12B-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A15C-01A-31D-A12B-09.bed.meta
manually_curated__id	tcga-e2-a15c-01a-31d-a12b-09
manually_curated__md5sum	3d9205ff0b1bd3ed6ae99c747e61df79
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	10c594a1-0843-4740-9d96-00211a9509fb
manually_curated__tumor_tag	brca
